Dr. Kaled Alektair, MD
Claim this profileClinical Trials Kaled Alektair, MD is currently running
More about Kaled Alektair, MD
Clinical Trial Related
3 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Kaled Alektair, MD has experience with
- Carboplatin
- Intensity-modulated Radiation Therapy
- Paclitaxel
Breakdown of trials Kaled Alektair, MD has run
Endometrial Cancer
Uterine Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kaled Alektair, MD specialize in?
Kaled Alektair, MD focuses on Endometrial Cancer and Uterine Cancer. In particular, much of their work with Endometrial Cancer has involved treating patients, or patients who are undergoing treatment.
Is Kaled Alektair, MD currently recruiting for clinical trials?
Yes, Kaled Alektair, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Kaled Alektair, MD has studied deeply?
Yes, Kaled Alektair, MD has studied treatments such as Carboplatin, Intensity-modulated radiation therapy, Paclitaxel.
What is the best way to schedule an appointment with Kaled Alektair, MD?
Apply for one of the trials that Kaled Alektair, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.